Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP632017.RACxqiiCSHkdznvVmEHc8KtvI7IKoMzeFPPslCRbmA-Qg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP632017.RACxqiiCSHkdznvVmEHc8KtvI7IKoMzeFPPslCRbmA-Qg130_assertion type Assertion NP632017.RACxqiiCSHkdznvVmEHc8KtvI7IKoMzeFPPslCRbmA-Qg130_head.
- NP632017.RACxqiiCSHkdznvVmEHc8KtvI7IKoMzeFPPslCRbmA-Qg130_assertion wasGeneratedBy ECO_0000203 NP632017.RACxqiiCSHkdznvVmEHc8KtvI7IKoMzeFPPslCRbmA-Qg130_provenance.
- NP632017.RACxqiiCSHkdznvVmEHc8KtvI7IKoMzeFPPslCRbmA-Qg130_assertion wasDerivedFrom befree-20150227 NP632017.RACxqiiCSHkdznvVmEHc8KtvI7IKoMzeFPPslCRbmA-Qg130_provenance.
- NP632017.RACxqiiCSHkdznvVmEHc8KtvI7IKoMzeFPPslCRbmA-Qg130_assertion SIO_000772 21387358 NP632017.RACxqiiCSHkdznvVmEHc8KtvI7IKoMzeFPPslCRbmA-Qg130_provenance.
- NP632017.RACxqiiCSHkdznvVmEHc8KtvI7IKoMzeFPPslCRbmA-Qg130_assertion evidence source_evidence_literature NP632017.RACxqiiCSHkdznvVmEHc8KtvI7IKoMzeFPPslCRbmA-Qg130_provenance.
- NP632017.RACxqiiCSHkdznvVmEHc8KtvI7IKoMzeFPPslCRbmA-Qg130_assertion description "[Acute promyelocytic leukaemia (APL) with t(15;17);PML-RARα (n = 7/18; 39%) harboured the highest frequency of FLT3 mutations, followed by myelomonocytic (n = 4/18; 22%) and AML with t(8;21);RUNX1-RUNX1T1 (n = 2/21; 9%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP632017.RACxqiiCSHkdznvVmEHc8KtvI7IKoMzeFPPslCRbmA-Qg130_provenance.